Consider the case of 7-year-old Matthew C., of Whittier, Calif., who went from being a high-risk asthma patient requiring multiple annual ED visits to being a low-risk patient who no longer requires any asthma medications. The difference is his use of an IQAir air purifier.
His mother Crystal says that almost every October and May, before Matthew started using an air purifier, she took him to the hospital when his quick-relief medication wasn't enough to stop an asthma attack. These ED visits and the rescue medications required to treat his attacks placed Matthew in the high-risk category.
His asthma attacks were triggered in the fall and spring, when airborne pollen and other triggers are most abundant. In 2009, he visited his pediatrician to be treated for asthma eight times. He visited the hospital emergency department twice.
In 2010, Crystal took home an IQAir HealthPro Plus room air purifier. She put the air purification system in Matthew's bedroom and immediately turned it on at its highest setting. That was in September, the beginning of another bad period for Matthew's asthma. It has run continuously since then.
Matthew's breathing improved immediately and dramatically the first night he slept in his bedroom with the IQAir HealthPro Plus running. He has not used his short-acting beta-agonist medication (albuterol) since then, in either nebulizer or canister form. For a period of time, his mother continued to carry the canister, and a canister is maintained at Matthew's school as well.
The impact of the IQAir HealthPro Plus on Matthew's non-drug asthma costs has been equally dramatic. For the first time in his life, he made it through the entire autumn, winter and spring seasons without a single trip to a hospital for an emergency injection. He has not been to the ED since. Obviously, the cost savings are substantial.
It's evident that use of the IQAir HealthPro Plus has had a major impact on the management of Matthew's asthma. Previously he was by definition a high asthma-risk case, and now he is managing his asthma at a very low asthma-risk level, resulting in an improved lifestyle and the elimination of costs on multiple levels.